Biolase Inc Reports Results For The Quarter Ended In December: Earnings Summary

November 26

17/03/2022 22:42

* BIOLASE Inc  BIOL.OQ  reported a quarterly adjusted loss
of 3
cents​​ per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for a loss of 2
cents per share.
    * Revenue rose 45.6% to $12.41 million from a year ago; 
analysts
expected $11.98 million. 
    * BIOLASE Inc's reported EPS for the quarter was a loss of 3
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * BIOLASE Inc shares had fallen by 13.3% this quarter.
    * The company reported a quarterly loss of $5.28 million.
    * Wall Street's median 12-month price target for BIOLASE Inc
is
$2.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 17 at 10:42 p.m.  ​All
figures in US dollars unless otherwise stated